The incidence of multiple myeloma (MM), the second most common hematologic malignancy, is rising globally [1]. Therefore, research efforts focused on identifying risk factors to reduce risk of MM are ...
As the spread of infectious diseases accelerates, technologies that can accurately distinguish multiple viruses in a single test are becoming increasingly important. KAIST and an international ...
Suboptimal dietary factors may contribute to an estimated 255 million disability-adjusted life years lost and 11 million deaths globally each year 1. Promoting healthy dietary patterns can be a potent ...
KEYNOTE-859: 4.5-year median follow-up of pembrolizumab plus chemotherapy for previously untreated advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. This is an ASCO ...
Real-world treatment patterns of triple-class refractory (TCR) multiple myeloma (MM) across the United States (US), Canada, and western Europe: A retrospective chart study. Most common treatment ...